NETWORK-1 TECHNOLOGIES, INC.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
NTIP$1.600.0%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Balance Sheets as of September 30, 2026 (unaudited) and December 31, 2025
CONDENSED CONSOLIDATED BALANCE SHEETS
| September 30, 2026 | December 31, 2025 | |
|---|---|---|
| ASSETS CURRENT ASSETS: · (Unaudited) | ||
| Cash and cash equivalents | $5,806,000 | $13,402,000 |
| Marketable securities, at fair value | 25,296,000 | 23,467,000 |
| Other current assets | 168,000 | 237,000 |
| TOTAL CURRENT ASSETS | 31,270,000 | 37,106,000 |
| OTHER ASSETS: | ||
| Patents, net of accumulated amortization | 1,722,000 | 1,479,000 |
| Equity investments | 2,786,000 | 1,734,000 |
| Security deposit | 13,000 | 13,000 |
| Total Other Assets | 4,521,000 | 3,226,000 |
| TOTAL ASSETS | $35,791,000 | $40,332,000 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY: CURRENT LIABILITIES: | ||
| Accounts payable | $1,366,000 | $253,000 |
| Accrued payroll | — | 289,000 |
| Other accrued expenses | 36,000 | 228,000 |
| Total Current Liabilities | 1,402,000 | 770,000 |
| LONG TERM LIABILITIES: | ||
| Deferred tax liability | 331,000 | — |
| TOTAL LIABILITIES | 1,733,000 | 770,000 |
| COMMITMENTS AND CONTINGENCIES (Note H) | ||
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at September 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.01 par value; authorized 50,000,000 shares; 22,905,681 and 22,824,009 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | 229,000 | 228,000 |
| Additional paid-in capital | 61,564,000 | 63,426,000 |
| Accumulated deficit | (27,735,000) | (24,092,000) |
| TOTAL STOCKHOLDERS’ EQUITY | 34,058,000 | 39,562,000 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $35,791,000 | $40,332,000 |
****CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| REVENUE | $— | $— | $— | $150,000 |
| OPERATING EXPENSES: | ||||
| Costs of revenue | — | — | — | 42,000 |
| Professional fees and related costs | 1,047,000 | 226,000 | 2,303,000 | 511,000 |
| General and administrative | 518,000 | 537,000 | 1,602,000 | 1,658,000 |
| Amortization of patents | 43,000 | 37,000 | 131,000 | 104,000 |
| TOTAL OPERATING EXPENSES | 1,608,000 | 800,000 | 4,036,000 | 2,315,000 |
| OPERATING LOSS | (1,608,000) | (800,000) | (4,036,000) | (2,165,000) |
| OTHER (LOSS) INCOME : | ||||
| Interest and dividend income, net | 421,000 | 467,000 | 1,155,000 | 1,396,000 |
| Gain on equity investment | — | — | 1,052,000 | — |
| Net realized and unrealized (loss) gain on marketable securities | (1,060,000) | 44,000 | (1,339,000) | 215,000 |
| Total other (loss) income, net | (639,000) | 511,000 | 868,000 | 1,611,000 |
| LOSS BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE | (2,247,000) | (289,000) | (3,168,000) | (554,000) |
| INCOME TAX PROVISION: | ||||
| Current | — | — | — | (31,000) |
| Deferred tax (benefit) expense, net | 86,000 | (83,000) | 331,000 | (232,000) |
| Total income tax (benefit) expense | 86,000 | (83,000) | 331,000 | (263,000) |
| LOSS BEFORE SHARE OF NET LOSS OF EQUITY METHOD INVESTEE: | (2,333,000) | (206,000) | (3,499,000) | (291,000) |
| SHARE OF NET LOSS OF EQUITY METHOD INVESTEE | — | (354,000) | — | (1,095,000) |
| NET LOSS | $(2,333,000) | $(560,000) | $(3,499,000) | $(1,386,000) |
| Net loss per share | ||||
| Basic | $(0.10) | $(0.02) | $(0.15) | $(0.06) |
| Diluted | $(0.10) | $(0.02) | $(0.15) | $(0.06) |
| Weighted average common shares outstanding: | ||||
| Basic | 22,867,447 | 22,807,916 | 22,839,263 | 22,858,180 |
| Diluted | 22,867,447 | 22,807,916 | 22,839,263 | 22,858,180 |
| Cash dividends declared per share | $0.05 | $0.05 | $0.10 | $0.10 |
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026
| Common Stock | |||||
|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-in Capital | Accumulated Deficit | Total Stockholders’ Equity | |
| Balance – January 1, 2026 | 22,824,009 | $228,000 | $63,426,000 | $(24,092,000) | $39,562,000 |
| Dividends and dividend equivalents declared | — | — | (998,000) | — | (998,000) |
| Stock-based compensation | — | — | 79,000 | — | 79,000 |
| Vesting of restricted stock units | 40,000 | 1,000 | (1,000) | — | — |
| Value of shares delivered to pay withholding taxes | (7,130) | — | — | (9,000) | (9,000) |
| Treasury stock purchased and retired | (60,996) | (1,000) | — | (84,000) | (85,000) |
| Net loss | — | — | — | (511,000) | (511,000) |
| Balance – March 31, 2026 | 22,795,883 | 228,000 | 62,506,000 | (24,696,000) | 38,038,000 |
| Dividends and dividend equivalents declared | — | — | — | — | — |
| Stock-based compensation | — | — | 42,000 | — | 42,000 |
| Vesting of restricted stock units | 7,500 | — | — | — | — |
| Value of shares delivered for acquisition of patents | 94,778 | 1,000 | 124,000 | — | 125,000 |
| Treasury stock purchased and retired | (34,980) | — | — | (51,000) | (51,000) |
| Net loss | — | — | — | (655,000) | (655,000) |
| Balance – June 30, 2026 | 22,863,181 | 229,000 | 62,672,000 | (25,402,000) | 37,499,000 |
| Dividends and dividend equivalents declared | — | — | (1,150,000) | — | (1,150,000) |
| Stock-based compensation | — | — | 42,000 | — | 42,000 |
| Vesting of restricted stock units | 42,500 | — | — | — | — |
| Treasury stock purchased and retired | — | — | — | — | — |
| Net loss | — | — | — | (2,333,000) | (2,333,000) |
| Balance – September 30, 2026 | 22,905,681 | $229,000 | $61,564,000 | $(27,735,000) | $34,058,000 |
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025
| Common Stock | |||||
|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-in Capital | Accumulated Deficit | Total Stockholders’ Equity | |
| Balance – January 1, 2025 | 22,961,619 | $229,000 | $65,455,000 | $(21,373,000) | $44,311,000 |
| Dividends and dividend equivalents declared | — | — | (1,171,000) | — | (1,171,000) |
| Stock-based compensation | — | — | 81,000 | — | 81,000 |
| Vesting of restricted stock units | 32,500 | — | — | — | — |
| Value of shares delivered to pay withholding taxes | (5,348) | — | — | (7,000) | (7,000) |
| Treasury stock purchased and retired | (106,662) | (1,000) | — | (149,000) | (150,000) |
| Net loss | — | — | — | (363,000) | (363,000) |
| Balance – March 31, 2025 | 22,882,109 | 228,000 | 64,365,000 | (21,892,000) | 42,701,000 |
| Stock-based compensation | — | — | 80,000 | — | 80,000 |
| Vesting of restricted stock units | 7,500 | — | — | — | — |
| Treasury stock purchased and retired | (44,811) | — | — | (57,000) | (57,000) |
| Net loss | — | — | — | (463,000) | (463,000) |
| Balance – June 30, 2025 | 22,844,798 | 228,000 | 64,445,000 | (22,412,000) | 42,261,000 |
| Dividends and dividend equivalents declared | — | — | (1,165,000) | — | (1,165,000) |
| Stock-based compensation | — | — | 66,000 | — | 66,000 |
| Vesting of restricted stock units | 32,500 | — | — | — | — |
| Treasury stock purchased and retired | (56,705) | — | — | (80,000) | (80,000) |
| Net loss | — | — | — | (560,000) | (560,000) |
| Balance – September 30, 2025 | 22,820,593 | $228,000 | $63,346,000 | $(23,052,000) | $40,522,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.